Loading...
•
Mar 31, 2024
Encompass Health Q1 2024 Earnings Report
Encompass Health's Q1 2024 performance was strong, driven by revenue and discharge growth, along with effective expense management, leading to increased profitability and positive outlook.
Key Takeaways
Encompass Health reported a strong first quarter with a 13.4% increase in revenue, driven by a 10.0% increase in discharges. Adjusted EBITDA grew by 19.2%, and the company increased its full-year guidance.
Revenue growth of 13.4% resulted primarily from discharge growth of 10.0%, including same-store growth of 6.7%. Net revenue per discharge grew 2.8%.
Cash flows provided by operating activities increased 4.8% to $238.8 million, primarily due to an increase in net income partly offset by changes in working capital.
Adjusted EBITDA increased 19.2%, primarily from increased revenue and overall expense management.
The Company increased its full-year guidance.
Forward Guidance
The Company increased its full-year guidance as follows: Net operating revenue $5,250 to $5,325 million, Adjusted EBITDA $1,030 to $1,065 million, Adjusted earnings per share from continuing operations attributable to Encompass Health $3.86 to $4.11
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...